Investment Thesis
While Envista demonstrates 8.3% revenue growth and healthy 55.3% gross margins, fundamental health is severely compromised by negative operating cash flow (-$3.3M) and negative free cash flow (-$15.8M) despite positive net income, indicating poor earnings quality and unsustainable cash burn. Combined with abysmal returns on equity (1.3%) and assets (0.7%), the company is destroying shareholder value through inefficient capital deployment and failing to convert reported profits into actual cash.
Strengths
- Revenue growing 8.3% year-over-year demonstrates ongoing market demand in dental sector
- Gross margin of 55.3% indicates strong product pricing power and underlying operational efficiency
- Strong liquidity position with 2.44x current ratio and $1.1B cash balance provides financial flexibility
Risks
- Negative operating cash flow and free cash flow signal earnings are not backed by cash generation; company is burning cash despite reported profitability
- Catastrophically poor capital efficiency with ROE of 1.3% and ROA of 0.7% indicates assets and shareholder equity are deployed with minimal returns
- Razor-thin net margin of 5.5% and operating margin of 8.9% leave no room for error and vulnerability to demand disruption
Key Metrics to Watch
- Operating cash flow inflection point and cash conversion rate of net income
- Free cash flow path to positive territory and working capital management
- Return on equity and asset efficiency trajectory over next 4 quarters
Financial Metrics
Revenue
705.5M
Net Income
38.7M
EPS (Diluted)
$0.23
Free Cash Flow
-15.8M
Total Assets
5.6B
Cash
1.1B
Profitability Ratios
Gross Margin
55.3%
Operating Margin
8.9%
Net Margin
5.5%
ROE
1.3%
ROA
0.7%
FCF Margin
-2.2%
Balance Sheet & Liquidity
Current Ratio
2.44x
Quick Ratio
2.06x
Debt/Equity
0.47x
Debt/Assets
0.0%
Interest Coverage
4.84x
Long-term Debt
1.4B
Disclaimer: This analysis is generated by AI based on publicly available SEC EDGAR filings.
It does not include stock price data and should not be considered financial advice.
All fundamental data is sourced from SEC public domain filings.
Always conduct your own research before making investment decisions.
Data Source: SEC EDGAR |
Analysis Date: 2026-05-08T11:38:46.687165 |
Data as of: 2026-04-03 |
Powered by Claude AI